Next-generation bioimaging

Commercialising the UK’s world-leading research is key to growing our economy. Enter Stream Bio, a UK-based SME whose Conjugated Polymer NanoparticlesTM, invented in the research labs of King’s College London, represent a new generation of innovative molecular bioimaging probes. These highly fluorescent, non-toxic nanoparticles are set to transform the bioimaging market with their unique brightness, exceptional stability, magnetic capability and suitability to be combined with a range of molecules.

Collaborating with CPI enabled Stream Bio to develop a commercially viable manufacturing process for this new product in four colours (or wavelengths), moving the product from idea to commercial reality. Now launched in the market, these nanoparticles are set to improve diagnostics and therapeutic targeting, with potential uses in imaging tumours and fluorescence-guided surgery. The increased accuracy this UK-made product can achieve could truly be a life-saver for millions of patients across the world.

 

Back to Annual Review